Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Afiveg
(aflibercept)
Uses, side effects, dosage information & price range
About this medicine
Afiveg is indicated for adults for the treatment of neovascular (wet) age-related macular degeneration (AMD) (see section 1), visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) (see section 5.1), visual impairment due to diabetic macular oedema (DME) (see section1), visual impairment due to myopic choroidal neovascularisation (myopic CNV) (see section 5.1).
Common Brand Names for this Composition
The following popular commercial brand names contain aflibercept as their active ingredient composition:
Afiveg
STADA Arzneimittel AG
Pavblu
Amgen Technology (Ireland) UC
Mynzepli
Advanz Pharma Limited
Eylea
Bayer AG
Afqlir
Sandoz GmbH
Yesafili
Biosimilar Collaborations Ireland Limited
Opuviz
Samsung Bioepis NL B.V.
Eydenzelt
Celltrion Healthcare Hungary Kft.
Eiyzey
Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
Eyluxvi
Biolitec pharma Limited Zweigniederlassung Jena
Baiama
Formycon AG
Ahzantive
Formycon AG
Vgenfli
Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
Skojoy
Amgen Technology (Ireland) UC
Zaltrap
Sanofi Winthrop Industrie
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
aflibercept
Category
Ophthalmologicals
Manufacturer
STADA Arzneimittel AG
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.